IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.14% | 8.29% | 19.77% | 45.61% | 40.97% |
| Total Depreciation and Amortization | -41.71% | -25.26% | -25.78% | -23.62% | 24.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -63.14% | -51.74% | -13.82% | -61.75% | -18.45% |
| Change in Net Operating Assets | 139.69% | -181.68% | 159.67% | 41.67% | -177.72% |
| Cash from Operations | 4.63% | -58.46% | 46.90% | 42.33% | 35.53% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 73.50% | 52.44% | 49.32% | 42.25% | -34.48% |
| Issuance of Common Stock | -- | -- | 65.70% | 284.78% | 54.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.97% | -105.01% | 65.27% | 1,041.90% | 55.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -400.67% | -768.09% | 129.44% | 59.22% | 147.94% |